These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31605037)

  • 1. The future of clinical trials in urological oncology.
    Narayan VM; Dahm P
    Nat Rev Urol; 2019 Dec; 16(12):722-733. PubMed ID: 31605037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, acceptability, appropriateness and appeal of a cancer clinical trials implementation intervention for rural- and minority-serving urology practices.
    Ellis S; Geana M; Griebling T; McWilliams C; Gills J; Stratton K; Mackay C; Shifter A; Zganjar A; Thrasher B
    Trials; 2019 Oct; 20(1):578. PubMed ID: 31590694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A primer on clinical trial design.
    Ellimoottil C; Vijan S; Flanigan RC
    Urol Oncol; 2015 Mar; 33(3):116-21. PubMed ID: 25624092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial intelligence in urological oncology: An update and future applications.
    Brodie A; Dai N; Teoh JY; Decaestecker K; Dasgupta P; Vasdev N
    Urol Oncol; 2021 Jul; 39(7):379-399. PubMed ID: 34024704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in Accrual and Race/Ethnicity Reporting in Urological and Nonurological Related Cancer Trials.
    Paul K; Sathianathen N; Dahm P; Le C; Konety BR
    J Urol; 2019 Aug; 202(2):385-391. PubMed ID: 31074679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Umbrella and basket trials in oncology: ethical challenges.
    Strzebonska K; Waligora M
    BMC Med Ethics; 2019 Aug; 20(1):58. PubMed ID: 31443704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reporting quality of randomised controlled trials in surgery: a systematic review.
    Agha R; Cooper D; Muir G
    Int J Surg; 2007 Dec; 5(6):413-22. PubMed ID: 18029237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in urologic oncology 'OncoForum': The best of 2014.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2015 Jun; 39(5):271-8. PubMed ID: 25770399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices.
    Ellis SD; Geana M; Mackay CB; Moon DJ; Gills J; Zganjar A; Brekke G; Thrasher JB; Griebling TL
    Urol Oncol; 2019 Aug; 37(8):529.e9-529.e18. PubMed ID: 30935846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future directions in urological oncology.
    Thompson RH
    BJU Int; 2015 Apr; 115(4):499. PubMed ID: 25808707
    [No Abstract]   [Full Text] [Related]  

  • 12. Urological medical oncology: land of opportunity.
    Jones R
    Future Oncol; 2013 Feb; 9(2):149-52. PubMed ID: 23414465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols.
    Park JJH; Siden E; Zoratti MJ; Dron L; Harari O; Singer J; Lester RT; Thorlund K; Mills EJ
    Trials; 2019 Sep; 20(1):572. PubMed ID: 31533793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic.
    Amparore D; Campi R; Checcucci E; Sessa F; Pecoraro A; Minervini A; Fiori C; Ficarra V; Novara G; Serni S; Porpiglia F
    Eur Urol Focus; 2020 Sep; 6(5):1032-1048. PubMed ID: 32553544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report from the 1st Japanese Urological Association-Japanese Society of Medical Oncology joint conference, 2006: 'A step towards better collaboration between urologists and medical oncologists'.
    Akaza H
    Int J Urol; 2007 May; 14(5):375-83. PubMed ID: 17511716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and cost-effectiveness studies in urologic oncology using large administrative databases.
    Wang Y; Mossanen M; Chang SL
    Urol Oncol; 2018 Apr; 36(4):213-219. PubMed ID: 29500134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary data sources for health services research in urologic oncology.
    Cole AP; Friedlander DF; Trinh QD
    Urol Oncol; 2018 Apr; 36(4):165-173. PubMed ID: 28911923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Active studies of the Working Association for Urological Oncology (AUO) in 2006].
    Rexer H
    Urologe A; 2006 Feb; 45(2):229-40. PubMed ID: 16440204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.